Topics

Lenalidomide may delay onset of myeloma-related bone, organ damage

06:42 EDT 28 Oct 2019 | Science Daily

The largest randomized trial in asymptomatic patients with smoldering multiple myeloma suggests that lenalidomide, a cancer drug, may delay the onset of bone and other myeloma-related organ damage.

Original Article: Lenalidomide may delay onset of myeloma-related bone, organ damage

NEXT ARTICLE

More From BioPortfolio on "Lenalidomide may delay onset of myeloma-related bone, organ damage"

Quick Search

Relevant Topics

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...